Weight loss medications like Ozempic, Wegovy, Mounjaro, and Zepbound are no longer just endocrine drugs — they’re rewriting perioperative safety. In this episode of the Super Nurse Podcast, we break down how GLP-1 receptor agonists disrupt gastric emptying, why traditional NPO rules may no longer protect patients, and how this creates real aspiration risk under anesthesia. You’ll learn what the research says, why the data seems paradoxical, and how frontline nurses are adapting in real time. Most importantly, this episode gives nurses — especially students and new grads — a clear, practical action plan to identify risk, ask the right questions, and advocate for airway safety before harm occurs.
GLP-1 receptor agonists intentionally slow gastric emptying
This effect improves weight loss but increases aspiration risk under anesthesia
Patients can follow NPO instructions perfectly and still arrive with a full stomach
Anesthesia removes protective airway reflexes
A full stomach increases the chance of gastric contents entering the lungs
Aspiration can cause chemical pneumonitis, pneumonia, respiratory failure, and death
Case reports and ultrasound studies show delayed gastric emptying lasting many hours or days
Large population studies show aspiration rates haven’t exploded
Possible explanation: tachyphylaxis — tolerance over time to gastric slowing
GLP-1 meds improve glucose control and wound healing
Weight loss reduces surgical risk factors like difficult airways and clotting risk
Cardiovascular benefits lower post-operative complications
Shift toward a 24-hour clear liquid diet before surgery
Holding weekly GLP-1 injections for a full seven days
Treating all GLP-1 patients as full stomach regardless of fasting status
Increased use of rapid sequence induction and endotracheal tubes
Growing use of point-of-care ultrasound to assess gastric contents
Develop a high index of suspicion for GLP-1 medications
Ask specifically when the last dose was taken
Assess for nausea, bloating, reflux, or early satiety
Ask what the patient ate, not just when they ate
Educate patients using lung safety, not blood sugar, as the rationale
Escalate concerns immediately — do not assume the case is canceled
Checklists alone are no longer enough
Nurses must investigate individual physiology, not just follow rules
Transparency and clinical judgment save lives
Host: All right, welcome back to the Super Nurse podcast. The energy in here today is uh something else because we are tackling a topic that is I mean it's probably the biggest curveball to hit perioperative nursing in years.
Guest: Oh, absolutely. It's one of those things where if you left nursing for say 5 years and came back today in 2026, you'd be totally lost in the preop area.
Host: You'd be like, wait, what happened to the rules?
Guest: Exactly. Why is everything completely different? It's this collision, you know, between a huge far trend and just basic surgical safety. But before we get into all that, we have to give a shout out to the person who built this whole thing. The Super Nurse podcast was created by Brooke Wallace.
Host: And for anyone new, Brooke is uh she's the real deal. We're talking 20 years in the ICU.
Guest: 20 years. And an organ transplant coordinator, clinical instructor, published author. I mean, she's worn pretty much every hat there is.
Host: She really has. And she built this platform and the AI powered courses that go with it with a really specific mission. It's not just about in getting through your shift, right? It's about arming the next generation of nurses to actually lead, not just follow a checklist.
Guest: So, if you want to be part of that, you should probably hit subscribe. You're going to want to see what's coming. But for today, we're talking about what everyone's calling the Ozempic surge.
Host: The Ozempic surge. It sounds so dramatic, right? But it is a very, very real clinical problem. We're looking at how these weight loss drugs, specifically the GLP-1 agonists, have just completely broken pre-operative assessment. And here's the hook. The old rules, you know, the NPO after midnight thing that's burned into every nurse's brain. It might not be safe enough anymore. And that's the scary part.
Guest: That is terrifying. You've got patients who do everything right. They follow every single instruction. They're totally compliant. And they're still rolling into the OR with a full stomach, which is an absolute nightmare for anesthesia. You think the tank's empty, but it's full of gas just waiting for a spark.
Host: So today, I kind of want to be the nursing student. I want to ask the questions that I know everyone's thinking in the break room and you can be the expert guide through all this.
Guest: Let's do it.
Host: Okay. First up, let's define what we're talking about. It's not just weight loss drugs in general, is it?
Guest: No, not at all. We are laser focused on a class called GLP-1 receptor agonists. And by now in 2026, these names are like everywhere.
Host: Oh yeah. Ozempic, Wegovy, right? That's semiglutide. And then you've got Mounjaro and Zepbound, which is tirzepatide. It feels like half the charts I look at have one of these on the med list.
Guest: They're ubiquitous and for good reason. They work wonders. But here's the irony. The very thing that makes them so good for weight loss is the exact same thing that makes them so dangerous under anesthesia.
Host: So, the pros, the con.
Guest: Precisely. These drugs work by causing delayed gastric emptying. The uh the clinical term is gastroparesis.
Host: Gastroparesis, which wait a minute, that's usually a disease, right? Like a pathology we treat in diabetics.
Guest: It is. But here we're kind of inducing it on purpose. The drug tells the stomach to just slow down. Hold on to the food.
Host: Exactly. Hold on to that food. Don't send it down the line yet. The patient feels full, so they eat less. It's brilliant for weight loss. But in a preop setting, I mean, the standard MO rule is 8 hours for solid food. Why eight?
Guest: Well, normally a stomach clears a meal in about 4 to 6 hours. So 8 hours gives you this big safety buffer. It's a standard that's worked for forever. And these drugs just erase that buffer. They don't just erase it, they obliterate it. We're seeing gastric emptying times delayed by I mean, not just hours, but sometimes days.
Host: Days. So, your patient eats dinner at 6:00 p.m. They stop eating like they're told, and they show up for surgery at 8:00 a.m. the next day. They follow the rules, but that dinner, it's still just sitting there.
Guest: Still sitting there.
Host: Okay, which leads us to the big one, pulmonary aspiration.
Guest: The absolute worst case scenario. It really is. When we put a patient to sleep, their protective reflexes like coughing and swallowing, they're gone. The sphincter at the top of the stomach relaxes and the stomach's full. The pressure just pushes everything up and it spills over into the lungs. And it's not like choking on water. This is stomach acid. It's chemical warfare on the lung, right? It causes chemical pneumonitis. It just destroys the alveoli. It can lead to a massive infection, pneumonia, and yes, it can be fatal. All from a routine surgery.
Host: So, the whole system, the checklist we've relied on for decades can fail even when everyone does their job. Right.
Guest: Yes.
Host: That's really unsettling.
Guest: It is. And it's created this really tense research landscape over the last couple of years. It's actually a bit of a paradox.
Host: How is it a paradox? Is the data fighting with itself?
Guest: It kind of is. Yeah. On one hand, you have what I call the panic data. The evidence of risk is just right. It's undeniable. We've got case reports from 2024, 2025.
Host: And what are they showing?
Guest: They're showing patients who fasted for 18, even 24 hours.
Host: 24 hours. You'd think their stomach would be bone dry.
Guest: You would think. And yet they go into do an endoscopy and they're solid food, not just liquid. Undigested food like they just ate an hour ago.
Host: That's wild.
Guest: And we can prove it's not a fluke. POCUS, that's point of care ultrasound, has become the gold standard here.
Host: Okay.
Guest: And studies using POCUS, show that consistently GLP-1 users have way higher amounts of fluid and food left in their stomachs than non-users. You can literally see it on the screen.
Host: I remember seeing FDA alerts about this, too.
Guest: Yeah, the FAERS data, the event system. It just lit up with reports of impaired gastric emptying and aspiration. So, you know, where there's smoke, there's fire.
Host: Okay. But you said paradox. So, what's the other side of the coin?
Guest: The other side comes from these huge cohort studies. I'm talking like 300,000 patients or more.
Host: Okay, that's a big sample size.
Guest: A massive one. And when they look at the hard outcomes, so actual rates of post-operative aspiration pneumonia, it hasn't skyrocketed.
Host: Wait, what? So, stomachs are full, but people aren't aspirating left and right. How does that work?
Guest: Well, the rate is higher for sure, but it's not the, you know, catastrophic explosion that some people feared, which suggests a couple of things. Either anesthesia providers are just really good at managing a known risk.
Host: Yeah.
Guest: Or there's this other factor at play.
Host: What is it?
Guest: A theory called tachyphylaxis.
Host: Tachyphylaxis. Okay. Break that down for me.
Guest: It basically just means tolerance. The body gets used to the drug over time. The theory is that this really dramatic stomach slowing mostly happens when you first start the drug or when you increase your dose.
Host: Ah, okay. So, if I've been on the same high dose of Ozempic for two years straight, my stomach might have like adapted.
Guest: Exactly. Your stomach might empty almost normally compared to someone who just took their very first shot last week. The newbie gut is paralyzed. The veteran gut has figured it out. But as the nurse doing the admission, that's the problem. You can't see tachyphylaxis.
Host: You can't. There's no meter for it. So, you're in this position where you have to assume everyone is high risk even if the data says it might be variable. This all sounds like such a massive headache. Which makes me wonder if it's causing this much chaos, why don't we just tell every patient to stop taking it weeks before surgery?
Guest: That's the million-dollar question. It's because we have to weigh the trade-offs, you can't just villainize the drug because it's um inconvenient for a 2-hour surgery.
Host: Okay, so play devil's advocate. Why keep them on it?
Guest: Well, first metabolic control. These drugs are incredible at lowering a patient since HBA1C. Better glucose control means better wound healing and fewer surgical site infections. That's huge.
Host: It is.
Guest: Then there's the weight loss itself. We all know obesity is a major surgical risk factor. DVTs, difficult airways, you name it. If a patient loses 50 lbs before their knee replacement, they are a much safer surgical candidate overall.
Host: And there's cardiac protection, too, right? It's seen some of that research.
Guest: Massive cardiac benefits. A reduction in what we call MACE—major adverse cardiovascular events. Fewer heart attacks, fewer strokes during recovery. So the patient walking in the door is often much healthier because of the drug.
Host: Okay. But then they hit the OR doors and we get the perioperative headache.
Guest: And that headache is real. We talked about the aspiration risk, but there's also just the misery of PONV, post-operative nausea and vomiting.
Host: Yeah, these drugs already cause nausea as a side effect. Then you add anesthesia, gas, and opioids on top of it. You've got a recipe for a very, very unhappy patient in the recovery room.
Guest: And nothing delays discharge like vomiting. Nothing. And then there the logistics, the cancellations. It happens every single day. A patient's prepped, the IV is in, the surgeon is scrubbing, and then someone finds out they took their weekly shot yesterday. Boom. Case canceled.
Host: Everyone's day is ruined. It cost the hospital a ton of money, and it's devastating for the patient. It's a mess. So, we've established the mess. Guidelines can be slow. Yeah. What are the people on the front lines, the boots on the ground actually doing? I know you hang out in the nursing and anesthesia forums. What's the word on the street?
Guest: I do. I love the forums. You see practice change there in real time way before it hits a textbook. And there are three big shifts happening that every nurse needs to know.
Host: Okay. What's number one?
Guest: The move to a 24-hour liquid diet.
Host: Wow. So, NPO after midnight is just out the window for these patients.
Guest: For a lot of them, yeah. Many places are now saying, "Listen, for the entire day before your surgery, you are on clear liquids only."
Host: It makes sense. If the conveyor belt is slow, don't put a brick on it. Put water on it.
Guest: Yeah, exactly. Liquid clears so much faster, even with gastroparesis. And if the worst happens and they do aspirate, clear liquid is far less damaging to the lungs than, you know, a piece of a cheeseburger, right?
Host: Okay. So, that's diet. What about the medication itself? Is there a consensus on when to hold it?
Guest: The hold protocol has gotten pretty solid. For weekly injections, the consensus is to hold for a full seven days before surgery, one full week. So, if my surgery's on a Tuesday and I take my shot on Friday, you skip that Friday dose, you need a full cycle for it to wash out. Now, if it's a daily oral pill, the half life is shorter. So, holding for just 24 hours is usually enough.
Host: And what about in the OR? How is anesthesia changing their approach?
Guest: This is a big one. Many CRNAs and anesthesiologists just they don't trust LMAs for these patients anymore.
Host: Okay, for any students listening, quick refresher. Yeah. LMA versus an ET, right?
Guest: An LMA, a laryngeal mask airway, just sits in the back of the throat. It's not a sealed system. So, if stomach contents come up, just slide right around it and into the lungs. Very risky. So now the default is becoming RSI, rapid sequence induction. They treat every single one of these patients as a full stomach, no matter what they say.
Host: And that means an endotracheal tube, an ET right down the windpipe.
Guest: That tube has an inflatable balloon cuff that creates a physical seal. It's the ultimate barrier. Nothing's going to pass that cuff. It's the safest option. And I've heard some places are even using tech to double check before they even go to the OR.
Host: That's the Third shift, POCUS in preop.
Guest: Some forward-thinking units are actually training their preop nurses to use a portable ultrasound so they can just take a quick peek at the stomach, like a gastric fuel gauge.
Host: That's a perfect way to put it. Yeah. If they see a bunch of contents, they can alert anesthesia to definitely use an ET or maybe even delay the case. It's becoming another vital sign. This is incredible. But let's bring it right down to the bedside. I'm a new grad. I'm doing my admission. Give me the super nurse action plan.
Guest: I love it. Okay. Number one, you need to develop your GLP-1 Spidey sense.
Host: Spidey sense. Okay.
Guest: If you hear a patient mention a weekly weight loss shot, your ears have to perk up. That's not just another home med. That is an airway safety alert.
Host: Got it. Step two. What questions do I ask?
Guest: Be super specific. Don't just ask, "Did you take your meds?" Ask, "When exactly was your last injection? What day and what time?" You need to do the math. If it's within 7 days, you have to flag it.
Host: And symptoms, too, right?
Guest: Crucial. Ask about any new or worsening nausea, bloating, or reflux. If your patient is telling you, you know, I just feel really full today, that is their body screaming that their stomach isn't emptying. That is a high-risk patient.
Host: Okay, here's one I think is so important. The last meal detail.
Guest: Yes, my favorite tip. Don't just ask when they last ate, ask what they ate.
Host: Why does the menu matter so much?
Guest: Because fat slows down digestion even more. So, if a patient on Ozempic had a big greasy last meal fried chicken, a fatty steak, even if it this 10 12 hours ago.
Host: That meal is probably still in there.
Guest: It's like a brick sitting in their stomach thanks to the combination of the fat and the drug. It's a huge danger signal.
Host: And what about explaining this to the patient? Because I can see them getting confused. They'll say, "My blood sugar is fine. I don't need to hold it."
Guest: This is where good patient education saves a life. A bad explanation is you need to hold this for your blood sugar. Because they'll just argue my sugar is 110.
Host: Exactly.
Guest: A good explanation, a super nurse explanation is this. We need you to hold this because it slows down how your stomach empties. If there's any food left in your stomach while you're asleep for surgery, it could come up and go into your lungs, which can be very dangerous.
Host: That changes everything. It's not about a rule, it's about their lung.
Guest: It makes it real. They get it.
Host: Okay, last scenario. The patient shows up and they forgot they took their shot yesterday. Do I just tell them, "Sorry, your surgery's canceled. Go home."
Guest: Absolutely not. That is the biggest rookie mistake. Do not assume the case is canceled.
Host: So what do I do?
Guest: You report it immediately. You go find the anesthesia provider and you tell them exactly what happened. They might not be thrilled, but if they know about the risk, they can usually manage it.
Host: So they might just switch their plan, right?
Guest: They'll just say, "Okay, thanks for the heads up. We'll use an endotracheal tube and do RSI." The danger isn't the drug. The danger is the secret.
Host: Transparency is safety. I love that. Wow. This has been so eye opening.
Guest: It really is a shift. And you know, if I can leave everyone with one final thought, Think about what this means for nursing judgment and go on.
Host: For so long, we've relied on these rigid checklists. NPO after midnight, check. All good. But in an era where a single medication can so drastically change a person's basic physiology, the checklist isn't enough.
Guest: We can't be robots.
Host: We can't. We have to be detectives. We have to investigate the specific patient context. And that is the difference between just being a good nurse and being a super nurse.
Guest: I love that. It's about critical thinking. So to wrap it up, GLP-1s slow digestion. The old NPO rules might not be enough. You got to ask the right questions about timing and what they ate. And you have to advocate for airway safety.
Host: You got it. That's the playbook. And remember, if you want to get ahead of curves just like this one, you have to check out super nurse.ai.
Guest: Oh, absolutely. What Brooke and the team are building there. Yeah. With the AI powered courses and resources, it's all designed to keep you from getting caught off guard by the next big thing.
Host: The medical world is changing fast. Don't get left behind. Go to super nurse.ai. Thank you so much for listening to the Super Nurse podcast.
Guest: Stay safe out there.